References
C.P. Page, W. Paul, A. Dewar, L.E. Wood, G.S. Basran, andJ. Morley, PAF-acether: a putative mediator of asthma and inflammation. InPharmacology of Asthma, (EdsJ. Morley andK. Rainsford). Agents and Actions13, 177–183 (1983).
W. Paul andC.P. Page,Cutaneous responses to synthetic platelet activating factor (PAF-acether) in the guinea-pig, Agents and Actions13, In press (1983).
B.B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort andF. Wal,Background and present status of research on platelet-activating factor (PAF-acether), Ann. N.Y. Acad. Sci.370, 119–137 (1981).
C.A. Demopoulos, G.E. Tsabikakis andV.M. Kapoulas,Intravascular pathobiology of acetyl glycerol ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). 1. Intravenous infusion in guinea-pigs, Immunol. Letters3, 133–135 (1981).
W.H. Anderson, S.F. Mohammed, A.Y.K. Chuang andR.G. Mason, Heparin potentiates synthesis of thromboxane A2 in human platelets. InAdvances in Prostaglandin and Thromboxane Research Vol. 6 (Eds.B. Sammuelson, P.W. Ramwell andR. Paoletti). Raven Press, New York, New York 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paul, W., Page, C.P., Cunningham, F.M. et al. The plasma protein extravasation response to PAF-acether is independent of platelet accumulation. Agents and Actions 15, 80–82 (1984). https://doi.org/10.1007/BF01966976
Issue Date:
DOI: https://doi.org/10.1007/BF01966976